急性脑梗死患者临床路径管理应用效果评价  

Application research on a clinical pathway for acute cerebral infarction

作　　者：李树浩[1] 邱浩强[1] 

机构地区：[1]广东省普宁华侨医院,广东揭阳515300

出　　处：《东南大学学报（医学版）》2014年第5期605-608,共4页Journal of Southeast University(Medical Science Edition)

摘　　要：目的:探讨临床路径管理在急性脑梗死治疗中的实施效果及应用价值。方法:采用回顾性队列研究的方式比较临床路径实施前后(2011年6月)急性脑梗死患者的相关情况,主要评价指标包括住院费用、疾病特征、诊疗质量等。结果:路径组的平均住院总费用、药费、检查费、床位费和平均住院天数均少于对照组,差异有统计学意义(P<0.05);而在手术费、治疗费和其他费用在路径组和对照组之间差异无统计学意义(P>0.05)。患者治疗效果比较发现,路径组的治愈率相较对照组更高,但两组治疗效果之间总体差异无统计学意义(P>0.05);路径组患者住院并发症发生率低于对照组,差异有统计学意义(P<0.05);两组之间病死率差异无统计学意义(P>0.05);两组患者入院与出院诊断符合率均为100%。结论:急性脑梗死临床路径管理可以缩短平均住院日、降低住院费用、提高诊疗质量,值得进一步推广。Objective：To evaluate the effects of the clinical path management in the treatment of acute cerebral infarction .Methods：A retrospective cohort study was applied to compare the status between the control group and the path group , the main evaluation indicators included hospital costs , disease characteristics , treatment quality . Results：Total cost of hospitalization , drugs fees, inspection fees , bed charges and the average hospitalization days in path group were less than those in the control group , the differences were statistically significant （ P〈0.05 ）;while in surgery , treatment costs and other expenses had no statistically significant differences between two groups （ P〉0.05 ） .The cure rate in path group was higher than that in the control group , but the overall difference between two groups was not statistically significant （ P〉0.05）; hospitalization incidence of complications in path group was higher than that in the control group （ P〈0.05）;mortality between the two groups showed no significant difference （ P 〉0 .05 ）; the diagnosis compatibility rate of patients discharged from hospital was 100%. Conclusion：Acute cerebral infarction path management can shorten the average length of stay , reduce hospital costs and improve quality of care , worthy of further promotion .

关 键 词：脑梗死 临床路径 效果评价 影响因素 

分 类 号：R743.33[医药卫生—神经病学与精神病学]